Kolexia
Bournaud Claire Endocrinologie
Bournaud Claire
Endocrinologie
Centre Hospitalier de Roanne
Roanne, France
101 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la thyroïde Carcinomes Maladies de la thyroïde Carcinome papillaire Adénocarcinome folliculaire Cancer papillaire de la thyroïde Tumeurs neuroendocrines Métastase lymphatique Ophtalmopathie basedowienne

Collaborateurs

Voir plus
Borson Chazot Francoise
Borson Chazot Francoise
Hôpital Louis Pradel, Bron, France
Leboulleux Sophie
Leboulleux Sophie
Gustave-Roussy, Villejuif, France
Zerdoud Slimane
Zerdoud Slimane
Oncopole Toulouse, Toulouse, France
Taieb David
Taieb David
Hôpital La Timone, Marseille, France

Industries

Voir plus
Pharma Dom
3 collaboration(s)
Dernière en 2023
AstraZeneca
3 collaboration(s)
Dernière en 2023
B3TSI
2 collaboration(s)
Dernière en 2023
PASCALEO
2 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
Estimabl2 trial: Thyroidectomy without radioiodine in patients with low-risk thyroid cancer, 5 years of follow-up
39e congrès de la Société Française d'Endocrinologie 2023   01 octobre 2023
MERAIODE: A Phase II Redifferentiation Trial with Trametinib and I in Metastatic Radioactive Iodine Refractory Mutated Differentiated Thyroid Cancer.
Thyroid : official journal of the American Thyroid Association   26 juillet 2023
A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research   06 juillet 2023
ESTIMABL2: Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients?
Essai Clinique (Gustave-Roussy)   16 mai 2023
Amino Acid Solutions for Lu-Oxodotreotide Premedication: A Tolerance Study.
Cancers   24 octobre 2022
Prognostic Impact of Microscopic Extra-Thyroidal Extension (mETE) on Disease Free Survival in Patients with Papillary Thyroid Carcinoma (PTC).
Cancers   24 mai 2022
Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer.
The New England journal of medicine   23 mars 2022
Safety and Efficacy of Peptide-Receptor Radionuclide Therapy in Elderly Neuroendocrine Tumor Patients.
Cancers   15 décembre 2021
MERAIODE: Efficacy of a Selective MEK (Trametinib) and BRAFV600E (Dabrafenib) Inhibitors Associated With Radioactive Iodine (RAI) for the Treatment of Refractory Metastatic Differentiated Thyroid Cancer With RAS or BRAFV600E Mutation
Essai Clinique (Gustave-Roussy)   27 septembre 2021
1743MO MERAIODE: A redifferentiation phase II trial with trametinib followed by radioactive iodine for metastatic radioactive iodine refractory differentiated thyroid cancer patients with a RAS mutation
Abstract Book of the ESMO Congress 2021, 16 – 21 September 2021   01 septembre 2021